Previous close | 142.00 |
Open | 141.17 |
Bid | 141.84 x 100 |
Ask | 142.05 x 100 |
Day's range | 140.17 - 142.30 |
52-week range | 89.04 - 148.37 |
Volume | |
Avg. volume | 848,730 |
Market cap | 14.281B |
Beta (5Y monthly) | 0.28 |
PE ratio (TTM) | 38.56 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 29 Dec 1995 |
1y target est | N/A |
Neurocrine Biosciences is making good on its promise to diversify from Ingrezza. Meanwhile, the biotech stock is angling for a record.
Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.
Neurocrine Biosciences ( NASDAQ:NBIX ) First Quarter 2024 Results Key Financial Results Revenue: US$515.3m (up 23% from...